Biotechnology of Bacillus Thuringiensis and its Environmental Impact’
The All India Crop Biotechnology Association (AICBA) in association with Indian Council of Agriculture Research (ICAR), Department of Biotechnology (DBT), and Calcutta University are organizing the 7th Pacific Rim Conference on the Biotechnology of Bacillus thuringiensis and its environmental impact – to be held at the [...]

ETBOND TECHNOLOGY defines Biotechnology approach to fight H1N1 Influenza A (Swine Flu)
1. Plan for Morbidity Reduction: H1N1 Influenza A (Swine Flu and its symptoms) is spreading at a lightening speed globally. It is infecting millions of patients since first reported in April, 2009 in Mexico. Costly quarantine and control measures are in place to [...]

Drives Industry through Partnerships, Innovation and Thought Leadership, 10th Edition of Bangalore Bio to be held from June 2nd to 4th 2010
The ninth edition of Bangalore Bio, successfully concluded today. Bangalore Bio, India’s premier Biotechnology event organized by the Department of Information Technology, Biotechnology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology [...]

Exhibitor Press Releases, Photos and Press Kits to Be Posted to the BIO Green Press Office Marking a Significant Commitment to Environmentally Friendly Press Center
2009 BIO International Convention
Virtual Press Office today announced it has been selected by the Biotechnology Industry Organization(BIO) to provide the official Green Press Office for the 2009 BIO International Convention. The [...]

Expands Bioanalytical and Immunoassay Capabilities into the United States
ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that is has acquired Prevalere Life Sciences Inc., a wholly owned subsidiary of ORS Labs Inc. Under the terms of the agreement ICON will pay [...]

ICON (NASDAQ:ICLR) (ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that at its Annual General Meeting held in Dublin yesterday, all resolutions put to the meeting were passed. These included a proposal for a bonus issue of one new ordinary share (or ADS) to the [...]

Strategic Combination Creates Premier Provider of Biotechnology Reagents and Systems
Transaction Valued at $6.7 Billion
Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the outstanding shares of Applera’s Applied Biosystems Group (NYSE: ABI) in a cash [...]